GF Fund Management’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.6K Buy
2,479
+1,558
+169% +$21.6K ﹤0.01% 504
2026
Q2
$22.6K Buy
921
+124
+16% +$2.24K ﹤0.01% 476
2026
Q1
$13.9K Buy
797
+93
+13% +$1.79K ﹤0.01% 532
2025
Q4
$9.31K Buy
+704
New +$6.24K ﹤0.01% 580

Other funds holding BIOA

GF Fund Management's BIOA Position: Q3 2026 in Review

GF Fund Management increased its BioAge Labs (BIOA) stake by 169% in Q3 2026, buying an estimated $21.6K and bringing the position to 2,479 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

GF Fund Management first reported a position in BIOA in Q4 2025 and has held it in 4 quarters since. The position peaked at $22.6K in Q2 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • GF Fund Management held 2,479 shares of BioAge Labs worth $17.6K as of Q3 2026.
  • GF Fund Management bought 1,558 BioAge Labs shares in Q3 2026, an estimated $21.6K.
  • BioAge Labs made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #504 holding.
  • GF Fund Management first reported a position in BioAge Labs in Q4 2025 and has held it in 4 quarters since.
  • GF Fund Management's BioAge Labs position peaked at $22.6K in Q2 2026.
  • 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.